Respiratory and Nutritional Support
At a Glance
In FTD-ALS, breathing and swallowing muscles can weaken. Caregivers should recognize emergency signs, ask about nighttime breathing checks, and discuss non-invasive ventilation, cough assist, and PEG feeding early according to the person’s goals.
As FTD-ALS progresses, the muscles that control breathing and swallowing will weaken. For caregivers, managing these changes is one of the most critical parts of the care plan. Because this condition involves both physical and cognitive changes, the timing and way these supports are introduced must be carefully managed to ensure comfort and safety [1][2].
Emergency vs. Urgent Medical Care
It is important to distinguish between the gradual changes typical of FTD-ALS and a medical emergency. Normal progression includes a slowly weakening voice, gradual fatigue, and needing more time to finish a meal [3].
Call Emergency Services (911) IMMEDIATELY if you notice:
- Inability to breathe, speak, or cough.
- Cyanosis: Lips, face, or fingertips turning blue or gray.
- Sudden, severe breathlessness or a rapid increase in the effort required to breathe.
- A severe choking episode with ongoing respiratory symptoms or an inability to clear the airway.
- Do not wait for a fever to seek emergency services for a breathing crisis. [3][4]
Call the care team soon (Same-Day) if you notice:
- Orthopnea: An inability to breathe while lying flat, often forcing the person to sleep sitting upright in a chair [5].
- New wet voice or prolonged meals: Sudden inability to manage saliva, progressive swallowing change, or new coughing during meals [6].
- Morning Headaches and Confusion: These can be signs that the body is not clearing enough carbon dioxide during sleep (nocturnal hypoventilation) [5][7].
Supporting the Lungs
Respiratory health is usually monitored regularly using tests like FVC (forced vital capacity) and SNIP (sniff nasal inspiratory pressure) [8][9]. Monitoring may need to be more frequent as symptoms change, and FVC/SNIP alone can miss nocturnal hypoventilation. A normal pulse-oximetry reading does not exclude carbon-dioxide retention.
- Non-Invasive Ventilation (NIV/BiPAP): This device uses a mask to push air into the lungs, giving the breathing muscles a rest. NIV can prolong survival and improve or maintain quality of life, particularly in patients with normal to moderately impaired bulbar function [10][11]. NIV benefit and tolerance vary from person to person.
- Cough Augmentation: A “cough assist” machine (mechanical insufflation-exsufflation) is used to augment an ineffective cough and help clear proximal secretions and respiratory infections. While it improves clearance, it cannot guarantee prevention of infection [12][8]. Frequency and settings must be prescribed by the respiratory team.
- The FTD Factor: Patients with behavioral changes or apathy may find the mask “claustrophobic” or may not understand why they need to wear it [13]. Successful use often requires starting with very short sessions during the day to “desensitize” the person before trying to use it all night [13][14].
Nutritional Support and the PEG Tube
When swallowing becomes unsafe or weight loss becomes rapid, a PEG tube (a small feeding tube placed through the abdomen) can provide necessary nutrition and hydration [15].
- Timing is Key: Decisions commonly consider respiratory decline, weight loss, dysphagia, and patient readiness. While older risk benchmarks suggested placing it while FVC was at least 50%, this is not a universal cutoff. It should be an early, individualized discussion based on goals and local expertise [15][16].
- Benefits: While a PEG tube does not stop the disease, it can stabilize weight and make it much easier to administer medications like Riluzole [15][4].
- Aspiration Warning: A feeding tube does not completely eliminate the risk of pneumonia, as a person can still aspirate their own saliva or “reflux” stomach contents into their lungs [4].
Managing Complex Decisions
Because FTD-ALS can affect a person’s ability to weigh complex pros and cons (executive dysfunction), it is vital to have “advance care” conversations early while the patient can still participate [1][2].
Caregivers should use supported decision-making: utilize yes/no signals, pictures, extra response time, and simple explanations rather than assuming that apathy or impaired speech equals refusal or incapacity. A caregiver acts as a legally authorized surrogate only when the patient lacks capacity under the applicable law; apathy, confusion, or difficulty speaking alone does not establish incapacity [2][17]. Formal assessment is required when a specific treatment decision is in question.
Common questions in this guide
Which FTD-ALS breathing symptoms require emergency help?
Can a normal oxygen reading rule out a breathing problem in FTD-ALS?
How can NIV or BiPAP help someone with FTD-ALS?
When should we discuss a PEG feeding tube?
Does a PEG tube prevent aspiration pneumonia?
What is a cough-assist machine used for?
How can caregivers support treatment decisions when FTD-ALS affects communication?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What were my loved one’s most recent seated and supine FVC (forced vital capacity) scores, and how do they compare to their baseline?
- 2.Does my loved one show signs of 'nocturnal hypoventilation,' such as morning headaches or daytime sleepiness, that might not show up on a simple oxygen check?
- 3.Given their behavioral changes, what specific strategies can we use to make them feel more comfortable and less 'claustrophobic' when starting NIV (BiPAP)?
- 4.When should we start discussing the option of a PEG tube to ensure the procedure is as safe as possible and aligned with our goals?
- 5.If the cough assist machine causes them to gag or feel distressed due to bulbar issues, whom should we contact to adjust the settings?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (17)
- 1
Amyotrophic lateral sclerosis: a clinical review.
Masrori P, Van Damme P
European journal of neurology 2020; (27(10)):1918-1929 doi:10.1111/ene.14393.
PMID: 32526057 - 2
Cognitive and behavioural impairment in amyotrophic lateral sclerosis.
Pender N, Pinto-Grau M, Hardiman O
Current opinion in neurology 2020; (33(5)):649-654 doi:10.1097/WCO.0000000000000862.
PMID: 32833751 - 3
Oropharyngeal Dysphagia as the Main Expression of Amyotrophic Lateral Sclerosis.
Rugaitienė M, Damulevičienė G, Lesauskaitė V, Ulozienė I
Medicina (Kaunas, Lithuania) 2022; (58(5)) doi:10.3390/medicina58050647.
PMID: 35630064 - 4
Distinct Clinical Features and Outcomes in Motor Neuron Disease Associated with Behavioural Variant Frontotemporal Dementia.
Cortés-Vicente E, Turon-Sans J, Gelpi E, et al.
Dementia and geriatric cognitive disorders 2018; (45(3-4)):220-231 doi:10.1159/000488528.
PMID: 29886477 - 5
Respiratory muscle testing in amyotrophic lateral sclerosis: a practical approach.
Sferrazza Papa GF, Pellegrino GM, Shaikh H, et al.
Minerva medica 2018; (109(6 Suppl 1)):11-19 doi:10.23736/S0026-4806.18.05920-7.
PMID: 30642145 - 6
Juvenile Amyotrophic Lateral Sclerosis: A Case Report of a Rare and Aggressive Presentation in a 22-Year-Old Filipino Male.
Po K, Olaivar M
Cureus 2024; (16(9)):e68579 doi:10.7759/cureus.68579.
PMID: 39371851 - 7
Respiratory phenotypes in amyotrophic lateral sclerosis as determined by respiratory questions on the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised and their relation to respiratory tests.
Pinto S, Oliveira Santos M, Gromicho M, et al.
European journal of neurology 2023; (30(6)):1594-1599 doi:10.1111/ene.15765.
PMID: 36872491 - 8
Airway Clearance Strategies and Secretion Management in Amyotrophic Lateral Sclerosis.
McHenry KL
Respiratory care 2024; (69(2)):227-237 doi:10.4187/respcare.11215.
PMID: 37816542 - 9
Correlations between measures of ALS respiratory function: is there an alternative to FVC?
Murray D, Rooney J, Al-Chalabi A, et al.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2021; (22(7-8)):495-504 doi:10.1080/21678421.2021.1908362.
PMID: 34590504 - 10
Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.
Radunovic A, Annane D, Rafiq MK, et al.
The Cochrane database of systematic reviews 2017; (10()):CD004427 doi:10.1002/14651858.CD004427.pub4.
PMID: 28982219 - 11
Effects of non-invasive ventilation on objective sleep and nocturnal respiration in patients with amyotrophic lateral sclerosis.
Boentert M, Brenscheidt I, Glatz C, Young P
Journal of neurology 2015; (262(9)):2073-82 doi:10.1007/s00415-015-7822-4.
PMID: 26076745 - 12
Provision, cough efficacy and treatment satisfaction of mechanical insufflation-exsufflation in a large multicenter cohort of patients with amyotrophic lateral sclerosis.
Maier A, Kettemann D, Weyen U, et al.
Scientific reports 2025; (15(1)):7360 doi:10.1038/s41598-025-91692-8.
PMID: 40025240 - 13
Which are the factors influencing NIV adaptation and tolerance in ALS patients?
Russo M, Bonanno C, Profazio C, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2021; (42(3)):1023-1029 doi:10.1007/s10072-020-04624-x.
PMID: 32710206 - 14
Optimizing the noninvasive ventilation pathway for patients with amyotrophic lateral sclerosis/motor neuron disease: a systematic review.
Baxter SK, Johnson M, Clowes M, et al.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2019; (20(7-8)):461-472 doi:10.1080/21678421.2019.1627372.
PMID: 31204525 - 15
A Comprehensive Examination of Percutaneous Endoscopic Gastrostomy and Its Association with Amyotrophic Lateral Sclerosis Patient Outcomes.
Bond L, Ganguly P, Khamankar N, et al.
Brain sciences 2019; (9(9)) doi:10.3390/brainsci9090223.
PMID: 31487846 - 16
Percutaneous endoscopic gastrostomy using the introducer method with ultra-slim endoscopy in amyotrophic lateral sclerosis patients with respiratory compromise: A safe technique.
Chuah KH, Yim CCW, Abdul Aziz NA, et al.
Journal of gastroenterology and hepatology 2022; (37(7)):1367-1372 doi:10.1111/jgh.15870.
PMID: 35470471 - 17
Screening for cognition in amyotrophic lateral sclerosis: test characteristics of a new screen.
Beeldman E, Govaarts R, de Visser M, et al.
Journal of neurology 2021; (268(7)):2533-2540 doi:10.1007/s00415-021-10423-x.
PMID: 33547953
This page is for informational purposes only and does not constitute medical advice. Caregivers should contact the FTD-ALS care team about respiratory changes, swallowing safety, NIV, and PEG decisions, and call emergency services for a breathing crisis.
Get notified when new evidence is published on Frontotemporal dementia with motor neuron disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.